The Evasive Enemy: Insights into the Virulence and Epidemiology of the Emerging Attaching and Effacing Pathogen
Overview
Affiliations
The diarrheic attaching and effacing (A/E) pathogen was first isolated from infants in Bangladesh in 1991, although the bacterium was initially classified as Subsequent genetic and biochemical interrogation of these isolates raised concerns about their initial taxonomic placement. It was not until 2003 that these isolates were reassigned to the novel taxon because they were genetically more closely related to , although they had diverged sufficiently to warrant a novel species name. Unfortunately, new isolates continue to be mistyped as enteropathogenic (EPEC) or enterohemorrhagic (EHEC) owing to shared traits, most notably the ability to form A/E lesions. Consequently, remains an underappreciated A/E pathogen, despite multiple reports demonstrating that many provisional EPEC and EHEC isolates incriminated in disease outbreaks are actually Metagenomic studies on dozens of isolates reveal a genetic architecture that boasts an arsenal of candidate virulence factors to rival that of its better-characterized cousins, EPEC and EHEC. Beyond these computational comparisons, studies addressing the regulation, structure, function, and mechanism of action of its repertoire of virulence factors are lacking. Thus, the paucity of knowledge about the epidemiology, virulence, and antibiotic resistance of , coupled with its misclassification and its ability to develop multidrug resistance in a single step, highlights the challenges in combating this emerging pathogen. This review seeks to synthesize our current but incomplete understanding of the biology of .
Zafar M, De Rauw K, Van den Abeele A, Joossens M, Heyvaert L, Houf K Microorganisms. 2025; 12(12.
PMID: 39770611 PMC: 11677093. DOI: 10.3390/microorganisms12122408.
Han Y, Kim S, Shin H, Kim H, Park J Front Immunol. 2024; 15:1451356.
PMID: 39502702 PMC: 11534669. DOI: 10.3389/fimmu.2024.1451356.
Phenotypic diversity of type III secretion system activity in enteropathogenic clinical isolates.
Contreras C, Hazen T, Guadarrama C, Cervantes-Rivera R, Ochoa T, Vinuesa P J Med Microbiol. 2024; 73(10).
PMID: 39432330 PMC: 11493143. DOI: 10.1099/jmm.0.001907.
Genetic distribution, characterization, and function of type III secretion system 2 (ETT2).
Wang X, Zhu H, Hu J, Zhang B, Guo W, Wang Z iScience. 2024; 27(5):109763.
PMID: 38706860 PMC: 11068852. DOI: 10.1016/j.isci.2024.109763.
Yuan T, Qazi I, Li J, Yang P, Yang H, Zhang X Front Plant Sci. 2023; 14:1206691.
PMID: 37680359 PMC: 10481342. DOI: 10.3389/fpls.2023.1206691.